The University’s research on development of vaccines against viral infectious diseases requires specialized expertise and saRNA related technology to carry out delivery, immunogenicity and minimal reactogenicity. Cytiva’s (formerly Precision Nanosystems) technology are essential for the development of saRNA and mRNA and manufacturing of LNP formulations and are critical for the departmental research and advancements in the field.
The University’s research on development of vaccines against viral infectious diseases requires specialized expertise and saRNA related technology to carry out delivery, immunogeni...
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.